Shuttle Pharmaceuticals Holdings Inc (NASDAQ: SHPH)’s stock price has gone rise by 8.81 in comparison to its previous close of 0.17, however, the company has experienced a 7.53% increase in its stock price over the last five trading days. globenewswire.com reported 2025-05-15 that GAITHERSBURG, Md., May 15, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today provided a corporate update.
Is It Worth Investing in Shuttle Pharmaceuticals Holdings Inc (NASDAQ: SHPH) Right Now?
Moreover, the 36-month beta value for SHPH is 0.40.
The public float for SHPH is 6.07M and currently, short sellers hold a 11.51% of that float. On June 04, 2025, SHPH’s average trading volume was 4.55M shares.
SHPH’s Market Performance
SHPH stock saw a decrease of 7.53% in the past week, with a monthly decline of -35.68% and a quarterly a decrease of -66.34%. The volatility ratio for the week is 4.53%, and the volatility levels for the last 30 days are 5.68% for Shuttle Pharmaceuticals Holdings Inc (SHPH). The simple moving average for the last 20 days is -9.59% for SHPH’s stock, with a simple moving average of -78.84% for the last 200 days.
SHPH Trading at -35.23% from the 50-Day Moving Average
After a stumble in the market that brought SHPH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.76% of loss for the given period.
#####
#####
Stock Fundamentals for SHPH
Current profitability levels for the company are sitting at:
- -1611.44 for the present operating margin
- -0.17 for the gross margin
The net margin for Shuttle Pharmaceuticals Holdings Inc stands at -1820.94. The total capital return value is set at -2.63. Equity return is now at value -346.19, with -208.00 for asset returns.
Based on Shuttle Pharmaceuticals Holdings Inc (SHPH), the company’s capital structure generated 0.25 points at debt to capital in total, while cash flow to debt ratio is standing at -7.8. The debt to equity ratio resting at 0.34. The interest coverage ratio of the stock is -10.81.
Currently, EBITDA for the company is -7.7 billion with net debt to EBITDA at 0.36. When we switch over and look at the enterprise to sales, we see a ratio of -242.12. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.78.
Conclusion
To wrap up, the performance of Shuttle Pharmaceuticals Holdings Inc (SHPH) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
